Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague

Vaccine

Volumn 26, Issue 13, 2008, Pages 1616-1625

  Zauberman, Ayelet ^a   Cohen, Sara ^a   Levy, Yinon ^a   Halperin, Gideon ^a   Lazar, Shirley ^a   Velan, Baruch ^a   Shafferman, Avigdor ^a   Flashner, Yehuda ^a   Mamroud, Emanuelle ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Immune correlates; LcrV; Y. pestis

Indexed keywords

IMMUNOGLOBULIN G; VIRULENCE FACTOR;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BACTERIAL INFECTION; CELL DEATH; CELL ISOLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PLAGUE; PRIORITY JOURNAL; SEROLOGY; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, BACTERIAL; CELL LINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION SCHEDULE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; LETHAL DOSE 50; MACROPHAGES; MICE; NEUTRALIZATION TESTS; PLAGUE; PORE FORMING CYTOTOXIC PROTEINS; RABBITS; VACCINES, SYNTHETIC; YERSINIA PESTIS;

EID: 40249116260     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.01.033     Document Type: Article

References (31)

1. Perry R., and Fetherston J. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 10 1 (1997) 35-66
2. Inglesby T.V., et al., Working Group on Civilian Biodefense. Plague as a biological weapon: medical and public health management. JAMA 283 17 (2000) 2281-2290
3. Titball R.W., and Williamson E.D. Yersinia pestis (plague) vaccines. Expert Opin Biol Ther 4 (2004) 965-973
4. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., and Ritball R.W. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15 (1997) 1079-1084
5. Andrews G.P., Strachan S.T., Benner G.E., Sample A.K., Anderson Jr. G.W., Adamovicz J.J., et al. Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect Immun 67 3 (1999) 1533-1537
6. Powell B.S., Andrews G.P., Enama J.T., Jendrek S., Bolt C., Worsham P., et al. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog 21 5 (2005) 1490-1510
7. Williamson E.D., Flick-Smith H.C., LeButt C., Rowland C.A., Jones S.M., Waters E.L., et al. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun 73 (2005) 3598-3608
8. Andrews G.P., Heath D.G., Anderson Jr. G.W., Welkos S.L., and Friedlander A.M. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun 64 6 (1996) 2180-2187
9. Anderson Jr. G.W., Leary S.E., Williamson E.D., Titball R.W., Welkos S.L., Worsham P.L., et al. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and negative strains of Yersinia pestis. Infect Immun 64 11 (1996) 4580-4585
10. Motin V.L., Nakajima R., Smirnov G.B., and Brubaker R.R. Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun 62 10 (1994) 4192-4201
11. Hill J., Leary S.E., Griffin K.F., Williamson E.D., and Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 65 11 (1997) 4476-4482
12. Weeks S., Hill J., Friedlander A., and Welkos S. Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb Pathog 32 5 (2002) 227-237
13. Mueller C.A., Broz P., Muller S.A., Ringler P., Erne-Brand F., Sorg I., et al. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310 5748 (2005) 674-676
14. Mills S., Boland A., Sory M., van der Smissen P., Kerbourch C., Finlay B., et al. Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc Natl Acad Sci USA 94 23 (1997) 12638-12643
15. Monack D., Mecsas J., Ghori N., and Falkow S. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci USA 94 19 (1997) 10385-10390
16. Ruckdeschel K., Roggenkamp A., Lafont V., Mangeat P., Heesemann J., and Rouot B. Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect Immun 65 11 (1997) 4813-4821
17. Zauberman A., Cohen S., Mamroud E., Flashner Y., Tidhar A., Ber R., et al. Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect Immun 74 6 (2006) 3239-3250
18. Garmory H.S., Freeman D., Brown K.A., and Titball R.W. Protection against plague afforded by immunization with DNA vaccines optimized for expression of the Yersinia pestis V antigen. Vaccine 22 8 (2004) 947-957
19. Williamson E.D., Flick-Smith H.C., Waters E., Miller J., Hodgson I., Le Butt C.S., et al. Immunogenicity of the rF1 + rV vaccine for plague with identification of potential immune correlates. Microb Pathog 42 1 (2007) 11-21
20. Bashaw J., Norris S., Weeks S., Trevino S., Adamovicz J.J., and Welkos S. Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin Vaccine Immunol 14 5 (2007) 605-616
21. Flashner Y., Mamroud E., Tidhar A., Ber R., Aftalion M., Gur D., et al. Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates. Infect Immun 72 2 (2004) 908-915
22. Ben-Gurion R., and Hertman I. Bacteriocin-like material produced by Pasteurella pestis. J Gen Microbiol 19 (1958) 289-297
23. Holzman T., Levy Y., Marcus D., Flashner Y., Mamroud E., Cohen S., et al. Production and purification of high molecular weight oligomers of Yersinia pestis F1 capsular antigen released by high cell density culture of recombinant Escherichia coli cells carrying the caf1 operon. Microb Cell Factories 5 Suppl. I (2006) 98-101
24. Leary S.E.C., Williamson E.D., Griffin K.F., Russell P., Eley S.M., and Titball R.W. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun 63 (1995) 2854-2858
25. Ruckdeschel K., Mannel O., Richter K., Jacobi C.A., Trulzsch K., Rouot B., et al. Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages. J Immunol 166 3 (2001) 1823-1831
26. Cornelis G.R., and Wolf-Watz H. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol 23 5 (1997) 861-867
27. Brubaker R.R. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 71 7 (2003) 3673-3681
28. Hill J., Copse C., Leary S., Stagg A.J., Williamson E.D., and Titball R.W. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis. Infect Immun 71 4 (2003) 2234-2238
29. Cowan C., Philipovskiy A.V., Wulff-Strobel C.R., Ye Z., and Straley S.C. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect Immun 73 9 (2005) 6127-6137
30. Elvin S.J., and Williamson E.D. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague. Microb Pathog 37 (2004) 177-184
31. Parent M.A., Berggren K.N., Kummer L.W., Wilhelm L.B., Szaba F.M., Mullarky I.K., et al. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun 73 (2005) 7304-7310